Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had revenue of $32.36M in the quarter ending June 30, 2026, a decrease of -19.54%. This brings the company's revenue in the last twelve months to $141.01M, up 33.72% year-over-year. In the fiscal year ending March 31, 2026, Elite Pharmaceuticals had annual revenue of $148.87M with 77.13% growth.

• Revenue (ttm): 141.01M
• Revenue Growth: +33.72%
• P/S Ratio: 1.97
• Revenue / Employee: 2.17M
• Employees: 65
• Market Cap: 277.90M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	148.87M	64.83M	77.13%
Mar 31, 2025	84.04M	27.42M	48.42%
Mar 31, 2024	56.63M	22.47M	65.79%
Mar 31, 2023	34.16M	1.89M	5.87%
Mar 31, 2022	32.26M	6.88M	27.11%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error